Sabre Ebitda from 2010 to 2024

SABR Stock  USD 3.73  0.06  1.63%   
Sabre Corpo EBITDA yearly trend continues to be relatively stable with very little volatility. EBITDA is likely to drop to about 104.2 M. During the period from 2010 to 2024, Sabre Corpo EBITDA destribution of quarterly values had range of 1.7 B from its regression line and mean deviation of  430,247,601. View All Fundamentals
 
EBITDA  
First Reported
2012-12-31
Previous Quarter
98 M
Current Value
106.3 M
Quarterly Volatility
150.2 M
 
Yuan Drop
 
Covid
Check Sabre Corpo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabre Corpo's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160 M, Interest Expense of 247.5 M or Total Revenue of 2.3 B, as well as many indicators such as Price To Sales Ratio of 0.5, Dividend Yield of 0.0094 or Days Sales Outstanding of 57.86. Sabre financial statements analysis is a perfect complement when working with Sabre Corpo Valuation or Volatility modules.
  
Check out the analysis of Sabre Corpo Correlation against competitors.
To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.

Latest Sabre Corpo's Ebitda Growth Pattern

Below is the plot of the Ebitda of Sabre Corpo over the last few years. It is Sabre Corpo's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabre Corpo's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Sabre Ebitda Regression Statistics

Arithmetic Mean439,478,777
Geometric Mean453,387,537
Coefficient Of Variation119.46
Mean Deviation430,247,601
Median644,884,000
Standard Deviation525,010,013
Sample Variance275635.5T
Range1.7B
R-Value(0.52)
Mean Square Error218012.7T
R-Squared0.27
Significance0.05
Slope(60,495,927)
Total Sum of Squares3858897.2T

Sabre Ebitda History

2024104.2 M
2023109.7 M
202257.5 M
2021-431.2 M
2020-730.3 M
2019770.6 M
2018969.4 M

About Sabre Corpo Financial Statements

Sabre Corpo shareholders use historical fundamental indicators, such as Ebitda, to determine how well the company is positioned to perform in the future. Although Sabre Corpo investors may analyze each financial statement separately, they are all interrelated. The changes in Sabre Corpo's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sabre Corpo's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA109.7 M104.2 M

Additional Tools for Sabre Stock Analysis

When running Sabre Corpo's price analysis, check to measure Sabre Corpo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabre Corpo is operating at the current time. Most of Sabre Corpo's value examination focuses on studying past and present price action to predict the probability of Sabre Corpo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabre Corpo's price. Additionally, you may evaluate how the addition of Sabre Corpo to your portfolios can decrease your overall portfolio volatility.